Cardiorenal syndrome: a complex series of combined heart/kidney disorders
- PMID: 21921607
- DOI: 10.1159/000329233
Cardiorenal syndrome: a complex series of combined heart/kidney disorders
Abstract
Over the last decade, it has become increasingly clear that the cardiovascular and renal systems are interdependent. Primary disorders of either system have been shown to disturb the other system. As a result, a class of cardiorenal syndrome (CRS) has been identified where in a vicious cycle is established in which acute/chronic dysfunction of either the kidney or the heart exacerbates the loss of function in the other organ. The ADQI organization has proposed a classification derived from a consensus conference held in 2008. CRS is classified as a disorder of the heart and kidneys whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction in the other. The general definition has been expanded into five subtypes: CRS type 1 = acute worsening of heart function (acute heart failure-acute coronary syndrome) leading to kidney injury and/or dysfunction; CRS type 2 = chronic abnormalities in heart function (chronic heart failure-chronic heart disease) leading to kidney injury or dysfunction; CRS type 3 = acute worsening of kidney function (acute kidney injury) leading to heart injury and/or dysfunction; CRS type 4 = chronic kidney disease (chronic kidney disease) leading to heart injury, disease and/or dysfunction; and CRS type 5 = systemic conditions leading to simultaneous injury and/or dysfunction of heart and kidney. A major problem with previous terminology was that it did not allow for identification of pathophysiological interactions occurring in the different types of combined heart/kidney disorders. The subdivision into different subtypes seems to provide a better approach to this syndrome.
Copyright © 2011 S. Karger AG, Basel.
Similar articles
-
Cardio-renal syndromes: a systematic approach for consensus definition and classification.Heart Fail Rev. 2012 Mar;17(2):151-60. doi: 10.1007/s10741-010-9224-0. Heart Fail Rev. 2012. PMID: 21197571
-
Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI).Contrib Nephrol. 2010;165:54-67. doi: 10.1159/000313745. Epub 2010 Apr 20. Contrib Nephrol. 2010. PMID: 20427956
-
[Cardio-renal axis: pathophysiological evidences and clinical implications].G Ital Nefrol. 2017 Mar;34(Suppl 69):4-10. G Ital Nefrol. 2017. PMID: 28682024 Italian.
-
Cardiorenal syndrome in critical care: the acute cardiorenal and renocardiac syndromes.Adv Chronic Kidney Dis. 2013 Jan;20(1):56-66. doi: 10.1053/j.ackd.2012.10.005. Adv Chronic Kidney Dis. 2013. PMID: 23265597 Review.
-
Cardio-renal syndromes: from foggy bottoms to sunny hills.Heart Fail Rev. 2011 Nov;16(6):509-17. doi: 10.1007/s10741-011-9226-6. Heart Fail Rev. 2011. PMID: 21259069 Review.
Cited by
-
Cellular apoptosis in the cardiorenal axis.Heart Fail Rev. 2016 Mar;21(2):177-89. doi: 10.1007/s10741-016-9534-y. Heart Fail Rev. 2016. PMID: 26852141 Review.
-
Advances in the pathogenesis of cardiorenal syndrome type 3.Oxid Med Cell Longev. 2015;2015:148082. doi: 10.1155/2015/148082. Epub 2015 Mar 4. Oxid Med Cell Longev. 2015. PMID: 25821551 Free PMC article. Review.
-
Temporal Change in Renoprotective Effect of Tolvaptan on Patients with Heart Failure: AURORA Study.J Clin Med. 2022 Feb 13;11(4):977. doi: 10.3390/jcm11040977. J Clin Med. 2022. PMID: 35207249 Free PMC article.
-
Epigenetics: a potential key mechanism involved in the pathogenesis of cardiorenal syndromes.J Nephrol. 2018 Jun;31(3):333-341. doi: 10.1007/s40620-017-0425-7. Epub 2017 Aug 5. J Nephrol. 2018. PMID: 28780716 Review.
-
Comorbid renal tubular damage and hypoalbuminemia exacerbate cardiac prognosis in patients with chronic heart failure.Clin Res Cardiol. 2016 Feb;105(2):162-71. doi: 10.1007/s00392-015-0899-z. Epub 2015 Jul 29. Clin Res Cardiol. 2016. PMID: 26220048
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials